These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
538 related items for PubMed ID: 24471928
1. Rings in drugs. Taylor RD, MacCoss M, Lawson AD. J Med Chem; 2014 Jul 24; 57(14):5845-59. PubMed ID: 24471928 [Abstract] [Full Text] [Related]
2. Expanding the medicinally relevant chemical space with compound libraries. López-Vallejo F, Giulianotti MA, Houghten RA, Medina-Franco JL. Drug Discov Today; 2012 Jul 24; 17(13-14):718-26. PubMed ID: 22515962 [Abstract] [Full Text] [Related]
3. Hydration patterns of rings in drugs and relationship to lipophilicity: A DFT study. Haritha M, Suresh CH. J Comput Chem; 2022 Mar 15; 43(7):477-490. PubMed ID: 34978337 [Abstract] [Full Text] [Related]
4. Biodiversity of small molecules--a new perspective in screening set selection. Petrone PM, Wassermann AM, Lounkine E, Kutchukian P, Simms B, Jenkins J, Selzer P, Glick M. Drug Discov Today; 2013 Jul 15; 18(13-14):674-80. PubMed ID: 23454345 [Abstract] [Full Text] [Related]
5. FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space. Kutchukian PS, Lou D, Shakhnovich EI. J Chem Inf Model; 2009 Jul 15; 49(7):1630-42. PubMed ID: 19527020 [Abstract] [Full Text] [Related]
6. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Meanwell NA. Chem Res Toxicol; 2011 Sep 19; 24(9):1420-56. PubMed ID: 21790149 [Abstract] [Full Text] [Related]
7. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. Blum LC, Reymond JL. J Am Chem Soc; 2009 Jul 01; 131(25):8732-3. PubMed ID: 19505099 [Abstract] [Full Text] [Related]
9. Pharmaceutical structure montages as catalysts for design and discovery. Njarðarson JT. Future Med Chem; 2012 May 01; 4(8):951-4. PubMed ID: 22650237 [Abstract] [Full Text] [Related]
11. Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products. Murray JB, Roughley SD, Matassova N, Brough PA. J Med Chem; 2014 Apr 10; 57(7):2845-50. PubMed ID: 24520903 [Abstract] [Full Text] [Related]
12. Activity profile relationships between structurally similar promiscuous compounds. Hu Y, Bajorath J. Eur J Med Chem; 2013 Nov 10; 69():393-8. PubMed ID: 24077530 [Abstract] [Full Text] [Related]
15. Chemical probes for biological systems. Garcia-Serna R, Mestres J. Drug Discov Today; 2011 Feb 10; 16(3-4):99-106. PubMed ID: 21093609 [Abstract] [Full Text] [Related]
17. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Pérot S, Sperandio O, Miteva MA, Camproux AC, Villoutreix BO. Drug Discov Today; 2010 Aug 10; 15(15-16):656-67. PubMed ID: 20685398 [Abstract] [Full Text] [Related]
18. Drugs in action. Eggert US, Superti-Furga G. Nat Chem Biol; 2008 Jan 10; 4(1):7-11. PubMed ID: 18084271 [No Abstract] [Full Text] [Related]
19. Combining Molecular Scaffolds from FDA Approved Drugs: Application to Drug Discovery. Taylor RD, MacCoss M, Lawson AD. J Med Chem; 2017 Mar 09; 60(5):1638-1647. PubMed ID: 27935308 [Abstract] [Full Text] [Related]
20. Crystallographic fragment screening. Badger J. Methods Mol Biol; 2012 Mar 09; 841():161-77. PubMed ID: 22222452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]